NCT02873975 2022-10-21A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair DeficiencyDana-Farber Cancer InstitutePhase 2 Completed27 enrolled 13 charts